Elutia (ELUT) News Today $1.75 -0.01 (-0.57%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ELUT Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Brokers Issue Forecasts for Elutia FY2026 EarningsJune 11, 2025 | americanbankingnews.comCantor Fitzgerald Weighs in on Elutia FY2026 EarningsElutia Inc. (NASDAQ:ELUT - Free Report) - Stock analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for Elutia in a research report issued on Monday, June 9th. Cantor Fitzgerald analyst R. Osborn forecasts that the company will post earnings per share of ($0.17) for the year. CanJune 10, 2025 | marketbeat.comElutia (NASDAQ:ELUT) Shares Down 1% - Time to Sell?Elutia (NASDAQ:ELUT) Stock Price Down 1% - Should You Sell?June 5, 2025 | marketbeat.comCANTOR FITZGERALD REITERATES ELUTIA STOCK RATING WITH $7 TARGETJune 4, 2025 | uk.investing.comElutia Strengthens Drug-Eluting Biomatrix Platform with Peer-Reviewed Publication of Novel EluPro™ Testing MethodMay 28, 2025 | globenewswire.comFY2025 EPS Estimates for Elutia Lifted by Cantor FitzgeraldElutia Inc. (NASDAQ:ELUT - Free Report) - Equities research analysts at Cantor Fitzgerald lifted their FY2025 earnings per share (EPS) estimates for Elutia in a note issued to investors on Monday, May 12th. Cantor Fitzgerald analyst R. Osborn now anticipates that the company will post earnings ofMay 16, 2025 | marketbeat.comElutia Inc. (ELUT) Q1 2025 Earnings Call TranscriptMay 11, 2025 | seekingalpha.comEarnings call transcript: Elutia Q1 2025 beats EPS forecast, stock risesMay 10, 2025 | uk.investing.comElutia Announces Strong First Quarter 2025 Financial Results Driven by 84% Sequential Growth in EluProâ„¢ SalesMay 8, 2025 | globenewswire.comElutia Inc. Ends Distribution Agreement with LeMaitreMay 6, 2025 | tipranks.comElutia Transitions to Direct Distribution of Its Cardiovascular Product PortfolioMay 1, 2025 | globenewswire.comElutia to Report First Quarter 2025 Financial Results on Thursday, May 8, 2025May 1, 2025 | globenewswire.comSilverarc Capital Management LLC Increases Stake in Elutia Inc. (NASDAQ:ELUT)Silverarc Capital Management LLC raised its holdings in Elutia Inc. (NASDAQ:ELUT - Free Report) by 8.3% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,782,271 shares of the company's stock after buying an additional 136,46April 24, 2025 | marketbeat.comElutia to Participate in Chardan’s Trending Issues in Drug Development Conference Series on April 29April 23, 2025 | finance.yahoo.comElutia to Participate in Chardan's Trending Issues in Drug Development Conference Series on April 29April 22, 2025 | globenewswire.comElutia Stock Short Interest Report | NASDAQ:ELUT | BenzingaApril 21, 2025 | benzinga.comElutia initiates EluPro clinical study to collect real-world outcome dataApril 21, 2025 | markets.businessinsider.comElutia Initiates EluPro™ Registry Study Designed to Generate Evidence Supporting the Use of EluPro in Real-World Clinical PracticeApril 21, 2025 | globenewswire.comElutia Inc. (NASDAQ:ELUT) Short Interest UpdateElutia Inc. (NASDAQ:ELUT - Get Free Report) saw a large increase in short interest in March. As of March 31st, there was short interest totalling 65,000 shares, an increase of 37.4% from the March 15th total of 47,300 shares. Based on an average trading volume of 42,600 shares, the days-to-cover ratio is currently 1.5 days. Currently, 0.3% of the company's stock are sold short.April 20, 2025 | marketbeat.comElutia confirms global tariff environment has no material impact on performanceApril 15, 2025 | markets.businessinsider.comElutia Confirms No Material Impact from Global TariffsApril 14, 2025 | globenewswire.comEluta Slumps on RecognitionApril 4, 2025 | baystreet.caEluPro™ Named as 2025 Edison Award WinnerApril 4, 2025 | markets.businessinsider.comElutia to Participate in Upcoming Investor ConferencesApril 3, 2025 | globenewswire.comElutia to Debut EluPro™ at HRS 2025 — Experience the Difference Biology MakesApril 2, 2025 | globenewswire.comElutia Inc. (NASDAQ:ELUT) Sees Large Drop in Short InterestElutia Inc. (NASDAQ:ELUT - Get Free Report) was the target of a significant decline in short interest in March. As of March 15th, there was short interest totalling 47,300 shares, a decline of 30.1% from the February 28th total of 67,700 shares. Based on an average daily volume of 45,300 shares, the days-to-cover ratio is currently 1.0 days. Approximately 0.2% of the shares of the company are short sold.March 31, 2025 | marketbeat.comElutia Inc. (NASDAQ:ELUT) Holdings Raised by AIGH Capital Management LLCAIGH Capital Management LLC grew its stake in shares of Elutia Inc. (NASDAQ:ELUT - Free Report) by 22.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,074,675 shares of the company's stocMarch 31, 2025 | marketbeat.comElutia announces GPO agreement with Advantus Health PartnersMarch 28, 2025 | markets.businessinsider.comElutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluPro™March 28, 2025 | markets.businessinsider.comElutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluProâ„¢March 27, 2025 | globenewswire.comElutia publishes new preclinical data in AntibioticsMarch 27, 2025 | markets.businessinsider.comElutia Advances Scientific Leadership with Publication of New Study on Antibiotic-Eluting Biologic EnvelopeMarch 25, 2025 | globenewswire.comElutia files $100M mixed securities shelfMarch 18, 2025 | markets.businessinsider.comShort Interest in Elutia Inc. (NASDAQ:ELUT) Drops By 29.8%Elutia Inc. (NASDAQ:ELUT - Get Free Report) was the recipient of a large decline in short interest in the month of February. As of February 28th, there was short interest totalling 67,700 shares, a decline of 29.8% from the February 13th total of 96,400 shares. Currently, 0.3% of the shares of the company are short sold. Based on an average trading volume of 41,100 shares, the short-interest ratio is presently 1.6 days.March 17, 2025 | marketbeat.comInsider Buying: Elutia Inc. (NASDAQ:ELUT) Director Buys 420,000 Shares of StockElutia Inc. (NASDAQ:ELUT - Get Free Report) Director Highcape Capital, L.P. purchased 420,000 shares of the company's stock in a transaction dated Monday, February 3rd. The shares were acquired at an average price of $2.50 per share, for a total transaction of $1,050,000.00. Following the purchase, the director now directly owns 9,520,232 shares of the company's stock, valued at approximately $23,800,580. The trade was a 4.62 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this link.March 14, 2025 | marketbeat.comElutia Inc. (NASDAQ:ELUT) Director Acquires $1,050,000.00 in StockMarch 14, 2025 | insidertrades.comElutia Inc. Q4 Loss DecreasesMarch 8, 2025 | nasdaq.comEarnings call transcript: Elutia Q4 2024 misses forecasts, stock dropsMarch 8, 2025 | uk.investing.comElutia Inc. (NASDAQ:ELUT) Q4 2024 Earnings Call TranscriptMarch 8, 2025 | msn.comElutia (NASDAQ:ELUT) Given Overweight Rating at Cantor FitzgeraldCantor Fitzgerald reaffirmed an "overweight" rating and issued a $8.00 price objective on shares of Elutia in a research report on Friday.March 8, 2025 | marketbeat.comQ4 2024 Elutia Inc Earnings CallMarch 7, 2025 | finance.yahoo.comElutia reports Q4 EPS (26c) vs. (40c) last yearMarch 7, 2025 | markets.businessinsider.comElutia (NASDAQ:ELUT) Releases Quarterly Earnings ResultsElutia (NASDAQ:ELUT - Get Free Report) released its earnings results on Thursday. The company reported ($0.26) EPS for the quarter.March 7, 2025 | marketbeat.comElutia Inc. (ELUT) Q4 2024 Earnings Call TranscriptMarch 6, 2025 | seekingalpha.comElutia Inc. Reports 18% Increase in BioEnvelope Sales Driven by EluPro CommercializationMarch 6, 2025 | quiverquant.comElutia Announces Fourth Quarter and Full Year 2024 Financial Results: Strong Demand for EluPro™ in Pilot Launch Sets the Stage for Full Commercial Roll-OutMarch 6, 2025 | globenewswire.comElutia (NASDAQ:ELUT) Stock Price Down 5.4% - Time to Sell?Elutia (NASDAQ:ELUT) Shares Down 5.4% - Time to Sell?March 1, 2025 | marketbeat.comElutia to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, March 6, 2025February 20, 2025 | globenewswire.comPrivate equity firms are Elutia Inc.'s (NASDAQ:ELUT) biggest owners and were hit after market cap dropped US$3.9mFebruary 8, 2025 | finance.yahoo.comElutia Inc. secures $15 million through stock and warrant saleFebruary 3, 2025 | msn.com Get Elutia News Delivered to You Automatically Sign up to receive the latest news and ratings for ELUT and its competitors with MarketBeat's FREE daily newsletter. Email Address ELUT Media Mentions By Week ELUT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ELUT News Sentiment▼1.290.90▲Average Medical News Sentiment ELUT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ELUT Articles This Week▼42▲ELUT Articles Average Week Get Elutia News Delivered to You Automatically Sign up to receive the latest news and ratings for ELUT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ALLO News Today GLUE News Today TRDA News Today CADL News Today GOSS News Today OLMA News Today CGC News Today TNXP News Today PROK News Today ANNX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ELUT) was last updated on 6/17/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWill I be blacklisted?The President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elutia Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elutia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ELUT Stock Free ELUT Stock Alerts